Developers with antibacterials in preclinical pipeline by type 2021
In 2021, there were 103 commercial developers worldwide that were progressing antibacterial agents, compared to just two foundations/non-profit developers. This statistic illustrates the categorization of developers of antibacterial agents worldwide from 2019 to 2021, by type.